Form D · Biotechnology
GENELINK INC
Orlando, FL · CIK 0000941020
Offering snapshot reported Apr 15, 2013 · SEC filing
- Reported sold
- $50K Offering amount: $600K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 4, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 15, 2013 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Oct 9, 2012 | Amendment | $1,575,000 | $1,360,000vs Jul 19, 2012 | 6 | SEC filing |
| Jul 19, 2012 | Initial | $215,000 | No comparison | 2 | SEC filing |
| Jan 10, 2011 | Initial | $465,000 | No comparison | 5 | SEC filing |
| Feb 18, 2010 | Initial | $150,000 | No comparison | 6 | SEC filing |
| Nov 19, 2009 | Initial | $260,500 | No comparison | 6 | SEC filing |
| Jun 24, 2009 | Initial | $42,500 | No comparison | 3 | SEC filing |
| Mar 13, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 3, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 19, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 28, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $48K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-195038
Assumes that all $600,000 of securities being offered will be sold in the offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| First Equity Capital Securities, Inc. | 30365 |
Source: Form D, filed Apr 15, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary J. Beeman | Executive |
| Douglas M. Boyle | Director |
| Robert Hoekstra | Director |
| Susan Hunt | Executive |
| Bernard L. Kasten | Director, Executive |
| James A Monton | Director |
| Robert P. Ricciardi | Director, Executive |
| John H. Souza | Director, Executive |
| Sharon Tahaney | Executive |
| Monte E. Taylor | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8250 Exchange Drive Suite 120
Orlando, FL, 32809
Orlando, FL, 32809